Precision Psychiatry Market Size, Share & Trends Analysis Report By Product Type (Products, Services), By Sample Type (Blood-Based, Non-Blood-Based), By Biomarker Type (Genetic Biomarker, Protein Biomarker), By Technology (Sequencing, Polymerase Chain Reaction, Microarray, Immunoassay, Liquid Chromatography/Mass Spectrometry), By Application (Alzheimer’s Disease, Parkinson’s Disease, Autism, Depression, Bipolar Disease), By End User (Academic & Research Institutions, Hospitals & Diagnostic Laboratories), By Region (North America, Europe, APAC, Middle East and Africa, LATAM), Forecasts, 2026–2034

Precision Psychiatry Market Size

The global precision psychiatry market size was valued at USD 1.43 billion in 2025 and is projected to grow from USD 1.68 billion in 2026 to USD 6.06 billion by 2034, registering a CAGR of 17.4% during the forecast period from 2026 to 2034. North America dominated the precision psychiatry market with a market share of 42.6% in 2025.

Precision psychiatry, a new discipline within precision medicine, seeks to identify and capitalize on individual differences in biology, lifestyle, environment, and social determinants of health to improve mental health prevention, diagnosis, and treatment. Neuropsychiatric illnesses influence all sectors of life and are responsible for a tremendous amount of misery, impairment, and even death, as is becoming increasingly apparent. The Center for Precision Psychiatry aims to integrate research and clinical practice to facilitate more accurate risk prediction, targeted prevention, accurate diagnosis, and effective therapies for psychiatric diseases. The market for psychiatrists consists of sales of psychiatrist services and related items by businesses (organizations, sole proprietors, and partnerships) that provide the diagnosis, treatment, and prevention of mental, emotional, and behavioral illnesses.

Psychiatrists maintain individual or group practices in their own offices (e.g., centers, clinics) or at the facilities of others, such as hospitals or HMO medical centers. The precision psychiatry sector is now expanding because of the reduced cost of sequencing, the increasing acceptance of inorganic growth tactics, and the worldwide increase in mental health burden. In addition, researchers' rising adoption of modern molecular diagnostic technologies to conduct genomic and proteomic studies about the genesis and expression of psychiatric illnesses is likely to be a significant factor driving market expansion.

Product Type Insights

The market is segmented into Products and Services. The market is split into Blood-Based and Non-Blood-Based based on sample type. The market is divided by Biomarker Types into Genetic biomarkers and Protein biomarkers. Sequencing (NGS and Traditional Sequencing), Polymerase Chain Reaction (RT-PCR and dPCR), Microarray, Immunoassay, and Liquid Chromatography/Mass Spectrometry segment the market based on technology. The market is categorized by Application into Alzheimer's Disease, Parkinson's Disease, Autism, Depression, and Bipolar Disease. The market is categorized by end-user into Academic and Research Institutions, Hospitals, and Diagnostic Laboratories.

Request Customizationto receive a tailored report.

Speak to an Analystto discuss market opportunities.

Regional Insights

North America has the highest level of market concentration for precision psychiatry. This is due to several factors, such as the significant funding infusion from governmental organizations for psychiatric disorder research, the rising prevalence of mental disorders, the growing awareness of precision medicine, and the rising awareness of early detection. Over the period covered by the forecast, it is anticipated that the rate of expansion in the Asia-Pacific region will be the highest.

Unlock Regional Insightsto access country-level data, & regional trends.

List of Key and Emerging Players in Precision Psychiatry Market